Advertisement · 728 × 90

Posts by Carlota Rubio-Perez

Post image

Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform www.cell.com/cell-report...

9 months ago 5 1 0 0
Post image

A must read for today's afternoon presented today at #AACR25 by C. Curtis: beatiful through work on classical breast cancer subtypes characterization shows deep similarity between HER2+ and ER+ high risk www.nature.com/articles/s41...

11 months ago 3 2 0 0

Closing plenary session with deeply interesting work presented by C. Curtis and @marleenkok.bsky.social on mTNBC and biomarkers of response to IO: published, almost and ongoing work

11 months ago 2 0 0 0
Video

At yesterday's opening ceremony, we asked the cancer community to stand together to make their voices heard in support of innovative cancer science and medicine. #CancerResearchSavesLives® #AACR25

11 months ago 50 25 1 1

Ingenious strategies by Igne Svane to improve TIL therapy activity based on optimization of antigen recognition: tumor cell reprogramming into DC-like, expansion from tumor fragments #AACR25

11 months ago 1 0 0 0
Post image

Great talk on CAR NK potential by Katy Rezvani: potent citotoxicity, unexpected durable response. Amazing clinical trial pipeline at @mdanderson.bsky.social

11 months ago 2 0 0 0
Post image

Great work on CAR-T improvement by Marcela Maus: beyond IFNg KO, CRISPR screening libraries in vivo and in vitro to look for the best candidates #AACR25

11 months ago 2 0 0 0
Post image Post image

Happy to be at #AACR25! Looking forward to witnessing new advances in #Immunotherapy and #CellTherapy 🧬🔬

11 months ago 2 1 0 0
Advertisement
Post image

Encouraging pre-clinical results for GBM patients: triple-comb (DXM + antiCSF1 + antiTGFB) inhibitis post RT scarring, a niche for tumor recurrence @johannajoyce.bsky.social #AACR25

11 months ago 2 0 0 0

Second plenary, continuing with genomics. ecDNA old but kind of new for oncologists, relevant clinical implications: resistance to targeted therapies, worse prognosis, immune supressive TME relationship @paulmischel.bsky.social #AACR

11 months ago 0 0 0 0
Post image

Kickoff talk of first plenary session on genomic evolution, impressive work: from non tumoral to pre-malignant stages by @imartincorena.bsky.social Bioinformatics opening of #AACR25

11 months ago 4 0 0 0
Post image

A way to start with @bsky.app ! 7 days of cutting edge cancer research #AACR25

11 months ago 3 0 0 0